Top 100 beste US Aktien 2025
Die Liste zeigt die US Aktien mit der besten Kursperformance im laufenden Jahr 2025.
Alle US Aktien mit einer Marktkapitalisierung größer 100 Mio USD werden für die Übersicht berücksichtigt.
Die Tabelle ist nach Performance sortiert: Auf Platz 1 die US Aktie mit dem stärksten Kursanstieg 2025 und dann die weiteren Aktien bis Rang 100.
Aktie | ISIN | Kursveränderung | |||
---|---|---|---|---|---|
#1 | ![]() | DeFi Development Corporation | US47100L3015 | 3.687,49 % | |
#2 | ![]() | Janover Common Stock | US47100L2025 | 3.687,49 % | |
#3 | ![]() | Kindly MD, Common Stock | US49457M1062 | 1.379,03 % | |
#4 | ![]() | Oncology Institute | US68236X1000 | 825,57 % | |
#5 | ![]() | ThredUp | US88556E1029 | 458,27 % | |
#6 | ![]() | Nuvve Holding | US67079Y1183 | 449,61 % | |
#7 | ![]() | Regulus Ther.compar | US75915K3095 | 415,82 % | |
#8 | ![]() | Aeva Technologies | US00835Q1031 | 391,37 % | |
#9 | ![]() | Vigileuroscience | US92673K1088 | 362,35 % | |
#10 | ![]() | Rapid Micro Biosystems | US75340L1044 | 317,77 % | |
#11 | ![]() | Nutex Health | US67079U1088 | 281,10 % | |
#12 | ![]() | Circle Internet Group, Inc. | US1725731079 | 278,06 % | |
#13 | ![]() | Upexi | US39959A2050 | 262,10 % | |
#14 | ![]() | Cantor Equity Partners I, Ordinaryes | KYG4491L1041 | 261,69 % | |
#15 | ![]() | CuriosityStream | US23130Q1076 | 256,27 % | |
#16 | ![]() | 908 Devices | US65443P1021 | 230,91 % | |
#17 | ![]() | Marblegate Acquisition | US56608A1051 | 228,20 % | |
#18 | ![]() | AltC Acquisition | US02156V1098 | 220,44 % | |
#19 | ![]() | OptimizeRX | US68401U2042 | 212,76 % | |
#20 | ![]() | Sezzle Common Stock | US78435P1057 | 207,74 % | |
#21 | ![]() | Digital Turbine | US25400W1027 | 207,10 % | |
#22 | ![]() | Lightbridge | US53224K3023 | 201,48 % | |
#23 | ![]() | I-Mab | US44975P1030 | 192,94 % | |
#24 | ![]() | CytomX Therapeutics | US23284F1057 | 173,79 % | |
#25 | ![]() | Spero Therapeutics | US84833T1034 | 171,84 % | |
#26 | ![]() | Groupon | US3994732069 | 168,81 % | |
#27 | ![]() | FuboTV | US35953D1046 | 167,46 % | |
#28 | ![]() | Dave | US23834J1025 | 166,53 % | |
#29 | ![]() | LifeMD | US53216B1044 | 155,15 % | |
#30 | ![]() | Grail, Llc | US3847471014 | 145,77 % | |
#31 | ![]() | Hims & Hers Health Registered (A) | US4330001060 | 138,05 % | |
#32 | ![]() | Neuronetics | US64131A1051 | 137,27 % | |
#33 | ![]() | Porch | US7332451043 | 132,11 % | |
#34 | ![]() | Nuscale Power | US67079K1007 | 132,01 % | |
#35 | ![]() | Navitas Semiconductor Corporation | US63942X1063 | 122,97 % | |
#36 | ![]() | American Oncology Network | US0287191029 | 117,39 % | |
#37 | ![]() | Barington/Hilco Acquisition | US22677T1025 | 115,26 % | |
#38 | ![]() | Root Registered (A) | US77664L1089 | 112,94 % | |
#39 | ![]() | Desktop Metal | US25058X1054 | 111,97 % | |
#40 | ![]() | Palvella Therapeutics, | US6979471090 | 111,00 % | |
#41 | ![]() | icad | US44934S2068 | 110,38 % | |
#42 | ![]() | Astronics | US0464331083 | 110,28 % | |
#43 | ![]() | Tempus AI Registered (A) | US88023B1035 | 109,66 % | |
#44 | ![]() | Accolade Inc | US00437E1029 | 105,26 % | |
#45 | ![]() | Microvast Holdings | US59516C1062 | 103,86 % | |
#46 | ![]() | AngloGold Ashanti | US0351282068 | 103,64 % | |
#47 | ![]() | Robinhood | US7707001027 | 100,97 % | |
#48 | ![]() | Invitation Homes | US46187W1071 | 96,12 % | |
#49 | ![]() | Pagaya Technologies Warrants | IL0011858912 | 95,80 % | |
#50 | ![]() | ASP Isotopes Common Stock | US00218A1051 | 94,26 % | |
#51 | ![]() | H&E Equipment Services | US4040301081 | 93,91 % | |
#52 | ![]() | Oportun Financial | US68376D1046 | 90,72 % | |
#53 | ![]() | Akero Therapeutics | US00973Y1082 | 90,35 % | |
#54 | ![]() | Agenus | US00847G8042 | 88,32 % | |
#55 | ![]() | Akebia Therapeutics | US00972D1054 | 87,89 % | |
#56 | ![]() | OppFi | US68386H1032 | 87,20 % | |
#57 | ![]() | Palantir | US69608A1088 | 80,34 % | |
#58 | ![]() | CorMedix | US21900C3088 | 80,12 % | |
#59 | ![]() | BeyondSpring | KYG108301006 | 78,53 % | |
#60 | ![]() | AnaptysBio | US0327241065 | 78,25 % | |
#61 | ![]() | Adaptive Biotechnologies | US00650F1093 | 77,31 % | |
#62 | ![]() | Exagen | US30068X1037 | 77,06 % | |
#63 | ![]() | Journey Medical | US48115J1097 | 76,73 % | |
#64 | ![]() | Soleno Therapeut. | US8342033094 | 76,08 % | |
#65 | ![]() | Flotek Industries | US3433894090 | 73,66 % | |
#66 | ![]() | Inmune Bio | US45782T1051 | 73,23 % | |
#67 | ![]() | ASTeMobile | US00217D1000 | 72,84 % | |
#68 | ![]() | Tutor Perini | US9011091082 | 72,69 % | |
#69 | ![]() | TSS Inc | US87288V1017 | 72,34 % | |
#70 | ![]() | nLight | US65487K1007 | 71,78 % | |
#71 | ![]() | ACM Research | US00108J1097 | 71,19 % | |
#72 | ![]() | 2Seventy Bio | US9013841070 | 70,06 % | |
#73 | ![]() | Genesis Energy | US3719271047 | 69,70 % | |
#74 | ![]() | NioCorp Developments | CA6544846091 | 69,03 % | |
#75 | ![]() | San Juan Basin Royalty | US7982411057 | 68,41 % | |
#76 | ![]() | Power | US73933G2021 | 68,03 % | |
#77 | ![]() | Faro | US3116421021 | 67,78 % | |
#78 | ![]() | Compass Therapeutics | US20454B1044 | 67,59 % | |
#79 | ![]() | Carvana | US1468691027 | 67,34 % | |
#80 | ![]() | Cloudflare | US18915M1071 | 66,89 % | |
#81 | ![]() | Ouster, Common Stock | US68989M2026 | 66,61 % | |
#82 | ![]() | NRG Energy | US6293775085 | 66,61 % | |
#83 | ![]() | Roblox Registered (A) | US7710491033 | 66,20 % | |
#84 | ![]() | Zscaler | US98980G1022 | 66,20 % | |
#85 | ![]() | Kingsway Financialrvices | US4969042021 | 65,34 % | |
#86 | ![]() | Nextracker Registered (A) | US65290E1010 | 64,66 % | |
#87 | ![]() | Argan | US04010E1091 | 64,48 % | |
#88 | ![]() | MP Materials | US5533681012 | 64,36 % | |
#89 | ![]() | Intrepid Potash | US46121Y2019 | 63,46 % | |
#90 | ![]() | Nuvectis Pharma | US67080T1088 | 63,22 % | |
#91 | ![]() | ASA Gold and Precious Metals | BMG3156P1032 | 63,08 % | |
#92 | ![]() | Paysign | US70451A1043 | 60,60 % | |
#93 | ![]() | Guardant Health | US40131M1099 | 60,49 % | |
#94 | ![]() | Coeur Mining | US1921085049 | 59,97 % | |
#95 | ![]() | Editas Medicine | US28106W1036 | 59,84 % | |
#96 | ![]() | Celsius | US15118V2079 | 59,72 % | |
#97 | ![]() | KalVista | US4834971032 | 58,91 % | |
#98 | ![]() | Douglas Elliman | US25961D1054 | 58,68 % |
Novartis hat am Mittwoch für einen vorbörslichen Paukenschlag gesorgt: Der Schweizer Pharmariese will das US-Biotechunternehmen Regulus Therapeutics übernehmen – für...
WeiterlesenWie Reuters berichtet, will US-Präsident Donald Trump per Dekret die heimische Atomindustrie deutlich stärken. Der Energiemarkt reagiert prompt: Zahlreiche Aktien...
WeiterlesenEin Paukenschlag an der Nasdaq: Die Aktie von Spero Therapeutics hat sich am Mittwoch im vorbörslichen Handel mehr als verdreifacht....
Weiterlesen